Miochol-E (Acetylcholine Chloride)

Miochol‑E acts on the ocular muscarinic pathway to produce controlled pupil constriction and facilitate fluid dynamics.

• Diagnostic ophthalmic procedures: provides reliable miosis to improve examination accuracy.
• Surgical ophthalmology: induces pupil constriction to enhance intra‑ocular surgical field visibility.
• Glaucoma adjunctive therapy: lowers intra‑ocular pressure by improving aqueous humor outflow.

• Acetylcholine chloride directly stimulates muscarinic (M3) receptors on the sphincter pupillae muscle, causing contraction and pupil constriction (miosis). The same muscarinic activation increases trabecular meshwork outflow, facilitating aqueous humor drainage and modestly reducing intra‑ocular pressure.

Miochol‑E may cause ocular and systemic reactions.

Common Side Effects

• Transient blurred vision: temporary loss of visual clarity after instillation.
• Eye irritation or burning: mild discomfort at the application site.
• Excessive tearing: increased lacrimation following dosing.
• Conjunctival redness: mild hyperemia of the eye.
• Headache: occasional mild headache after use.
• Mild ocular pain: brief discomfort in the treated eye.

Serious or Rare Side Effects

• Severe ocular inflammation: uveitis or iritis requiring immediate attention.
• Allergic reaction: swelling, rash, or hives around the eye.
• Systemic cholinergic effects: bradycardia, hypotension, or bronchospasm.
• Persistent miosis: prolonged pupil constriction affecting vision.
• Corneal edema: swelling of the cornea that may impair vision.
• Vision loss: rare but serious loss of visual acuity.

Before using Miochol‑E, consider the following safety measures.

• Contraindication assessment: avoid in patients with narrow‑angle glaucoma or known hypersensitivity.
• Intra‑ocular pressure monitoring: check pressure before and after administration.
• Caution with systemic cholinergic drugs: assess for additive effects.
• Avoid use in patients on anticholinergic therapy that may diminish efficacy.
• Educate patients on signs of serious adverse reactions.
• Store at room temperature: keep in the original container, protect from light and moisture.

Miochol‑E can interact with other agents affecting cholinergic pathways.

Major Interactions (Avoid)

• Systemic cholinesterase inhibitors: may cause excessive cholinergic stimulation.
• Other muscarinic agonists: additive ocular constriction and systemic effects.

Moderate Interactions (Monitor Closely)

• Anticholinergic medications: may reduce therapeutic response.
• Beta‑blocker eye drops: potential additive intra‑ocular pressure reduction.
• Systemic antihistamines: possible interference with ocular response.